Consultation Responses

Legislative Consent Memorandum – Health Service Medical Supplies (Costs) Bill

Community Pharmacy Scotland response to Health and Sport Committee of the Scottish Parliament call for views on Legislative Consent Memorandum – Health Service Medical Supplies (Costs) Bill

Mental Health in Scotland - A 10 year vision

Community Pharmacy Scotland responds to the consultation on the Scottish Government's plans for Mental Health provision over the next decade

Human Medicine Regulations 2012

Community Pharmacy Scotland responds to the consultation on the amendment to the Human Medicine Reglations 2012 otherwise known as 'Spoke and Hub'.

Statutory Scheme Consultation

A recent consultation response on behalf of members on the UK wide Statutory Scheme for medicine pricing.

National Care Standards Consultation

Community Pharmacy Scotland response to the call for views on the overarching principles that will form the basis of national care standards. These standards will apply to all health and social care settings across Scotland.

Health and Sport Committee Submissions

Community Pharmacy Scotland have recently replied to calls for evidence from the Health and Sport Committee at Holyrood on two subjects: We need to talk about Palliative Care and the Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill. On the latter consultation CPS have been asked to give oral evidence on Tuesday 8th September 2015 to the committee.

We have responded to three further consultations from the Health and Sport Committee July 2017: Technology and Innovation in the NHSDraft Budget 2018-2019 and Clinical Governance

Public Health Review Engagement Response

CPS have responded to a call for stakeholders to submit views to the Public Health Review announced by Scottish Ministers in November 2014. The review is chaired by Dr Hamish Wilson and looks for stakeholder views on the key challenges and potential opportunities for public health. The response was submitted by the deadline of 12th March 2015 and can be viewed here.